No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Hidradenitis Suppurativa (HS) is a chronic, inflammatory skin condition that affects the sweat glands and hair follicles. It is characterized by recurrent, painful, and inflamed nodules, abscesses, and scarring. Treatment for HS typically involves a combination of topical and systemic medications, including antibiotics, anti-inflammatory drugs, and immunosuppressants.
The HS drug market is a subset of the larger dermatological drug market. It is composed of a variety of medications used to treat HS, including antibiotics, anti-inflammatory drugs, and immunosuppressants. These drugs are used to reduce inflammation, reduce pain, and prevent further progression of the disease.
Some companies in the HS drug market include AbbVie, Amgen, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. Show Less Read more
